CLINICAL_TRIALS
trial_result
· 2012-01-26
Clinical Trial Update: Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia [Phase 4]
Summary
A Phase 4 trial evaluating milnacipran in fibromyalgia patients with inadequate response to duloxetine has completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 4 | Status: COMPLETED | Results posted: 2012-01-26